Trial Outcomes & Findings for Maximizing the Dietary Pattern of Older Adults: the Effects of Protein Intake on Protein Kinetics (NCT NCT04830514)

NCT ID: NCT04830514

Last Updated: 2023-08-24

Results Overview

Isotope Tracer

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

44 participants

Primary outcome timeframe

24 hour

Results posted on

2023-08-24

Participant Flow

Participant milestones

Participant milestones
Measure
Recommended Dietary Allowance (RDA) for Protein
(RDA; 0.8g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks. Recommended Dietary Allowance of Protein: 0.8 g/kg/day protein intake
Habitual Protein Intake Consistent With Population Level Norms
(NHANES; 1.0g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks. Habitual protein intake: 1.0 g/kg/day protein intake
Optimal Protein Intake (OPI)
(OPI; 1.5g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks. Optimal Protein Intake: 1.5 g/kg/day protein intake
Overall Study
STARTED
18
14
12
Overall Study
COMPLETED
10
11
9
Overall Study
NOT COMPLETED
8
3
3

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Maximizing the Dietary Pattern of Older Adults: the Effects of Protein Intake on Protein Kinetics

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Recommended Dietary Allowance (RDA) for Protein
n=10 Participants
(RDA; 0.8g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks. Recommended Dietary Allowance of Protein: 0.8 g/kg/day protein intake
Habitual Protein Intake Consistent With Population Level Norms
n=11 Participants
(NHANES; 1.0g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks. Habitual protein intake: 1.0 g/kg/day protein intake
Optimal Protein Intake (OPI)
n=9 Participants
(OPI; 1.5g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks. Optimal Protein Intake: 1.5 g/kg/day protein intake
Total
n=30 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Age, Categorical
Between 18 and 65 years
7 Participants
n=5 Participants
8 Participants
n=7 Participants
9 Participants
n=5 Participants
24 Participants
n=4 Participants
Age, Categorical
>=65 years
3 Participants
n=5 Participants
3 Participants
n=7 Participants
0 Participants
n=5 Participants
6 Participants
n=4 Participants
Sex: Female, Male
Female
5 Participants
n=5 Participants
6 Participants
n=7 Participants
6 Participants
n=5 Participants
17 Participants
n=4 Participants
Sex: Female, Male
Male
5 Participants
n=5 Participants
5 Participants
n=7 Participants
3 Participants
n=5 Participants
13 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
10 Participants
n=5 Participants
11 Participants
n=7 Participants
9 Participants
n=5 Participants
30 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
1 Participants
n=4 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
1 Participants
n=7 Participants
0 Participants
n=5 Participants
2 Participants
n=4 Participants
Race (NIH/OMB)
White
9 Participants
n=5 Participants
10 Participants
n=7 Participants
7 Participants
n=5 Participants
26 Participants
n=4 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
1 Participants
n=4 Participants
Region of Enrollment
United States
10 participants
n=5 Participants
11 participants
n=7 Participants
9 participants
n=5 Participants
30 participants
n=4 Participants

PRIMARY outcome

Timeframe: 24 hour

Isotope Tracer

Outcome measures

Outcome measures
Measure
Recommended Dietary Allowance (RDA) for Protein
n=10 Participants
(RDA; 0.8g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks. Recommended Dietary Allowance of Protein: 0.8 g/kg/day protein intake
Habitual Protein Intake Consistent With Population Level Norms
n=11 Participants
(NHANES; 1.0g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks. Habitual protein intake: 1.0 g/kg/day protein intake
Optimal Protein Intake (OPI)
n=9 Participants
(OPI; 1.5g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks. Optimal Protein Intake: 1.5 g/kg/day protein intake
Whole Body Protein Turnover
-0.16 g/kg lean body mass/day
Standard Deviation 0.08
-0.17 g/kg lean body mass/day
Standard Deviation 0.11
0.48 g/kg lean body mass/day
Standard Deviation 0.11

Adverse Events

Recommended Dietary Allowance (RDA) for Protein

Serious events: 1 serious events
Other events: 6 other events
Deaths: 0 deaths

Habitual Protein Intake Consistent With Population Level Norms

Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths

Optimal Protein Intake (OPI)

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Recommended Dietary Allowance (RDA) for Protein
n=18 participants at risk
(RDA; 0.8g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks. Recommended Dietary Allowance of Protein: 0.8 g/kg/day protein intake
Habitual Protein Intake Consistent With Population Level Norms
n=14 participants at risk
(NHANES; 1.0g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks. Habitual protein intake: 1.0 g/kg/day protein intake
Optimal Protein Intake (OPI)
n=12 participants at risk
(OPI; 1.5g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks. Optimal Protein Intake: 1.5 g/kg/day protein intake
Skin and subcutaneous tissue disorders
Laceration from fall
5.6%
1/18 • Number of events 1 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.
0.00%
0/14 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.
0.00%
0/12 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.

Other adverse events

Other adverse events
Measure
Recommended Dietary Allowance (RDA) for Protein
n=18 participants at risk
(RDA; 0.8g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks. Recommended Dietary Allowance of Protein: 0.8 g/kg/day protein intake
Habitual Protein Intake Consistent With Population Level Norms
n=14 participants at risk
(NHANES; 1.0g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks. Habitual protein intake: 1.0 g/kg/day protein intake
Optimal Protein Intake (OPI)
n=12 participants at risk
(OPI; 1.5g/kg/day) Protein intakes will be structured within two meals per day. A 2-day dietary lead-in will precede each dietary intervention. Study duration per subject will last about two weeks. Optimal Protein Intake: 1.5 g/kg/day protein intake
Skin and subcutaneous tissue disorders
Laceration from fall
0.00%
0/18 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.
0.00%
0/14 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.
8.3%
1/12 • Number of events 1 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.
Ear and labyrinth disorders
Dizziness
27.8%
5/18 • Number of events 5 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.
14.3%
2/14 • Number of events 2 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.
41.7%
5/12 • Number of events 5 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.
Gastrointestinal disorders
Nausea
22.2%
4/18 • Number of events 4 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.
14.3%
2/14 • Number of events 2 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.
16.7%
2/12 • Number of events 2 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.
Gastrointestinal disorders
Vomiting
16.7%
3/18 • Number of events 3 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.
7.1%
1/14 • Number of events 1 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.
8.3%
1/12 • Number of events 1 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.
Gastrointestinal disorders
GI illness with reflux
5.6%
1/18 • Number of events 1 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.
0.00%
0/14 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.
0.00%
0/12 • Starting with enrollment and ending with completion of last study visit; in most cases within 30 days.

Additional Information

David D. Church, Ph.D., Assistant Professor

University of Arkansas for Medical Sciences

Phone: 5015265709

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place